GGrantIndex
Sort

11,323 grants matching glioblastoma

Project 3: Inhibition of radiation-induced phenotype conversion in glioblastoma

$353,405
Frank Pajonk · University Of California Los Angeles · P50 · FY2020 · CA

Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma

$353,385
Linda M Liau · University Of California Los Angeles · P50 · FY2020 · CA

Therapeutically relevant targets of Twist1 dimers in glioma

$353,281
Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2020 · NS

Therapeutically relevant targets of Twist1 dimers in glioma

$353,281
Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2019 · NS

The hypoxic niche in glioblastoma is maintained by myeloid produced creatine

$353,256
Jason Miska · Northwestern University At Chicago · R01 · FY2024 · CA

High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment

$353,192
Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · CA

Systemic RNA interference to reactivate p53 tumor suppression

$353,176
Alexander H. Stegh · Northwestern University At Chicago · R01 · FY2020 · CA

Lassa-VSV targets and kills glioma, and is not neurotoxic

$353,156
Anthony N Van Den Pol · Yale University · R01 · FY2015 · CA

Computational and Experimental Modeling of Alternative Polyadenylation

$353,100
Wei Li · University Of California-Irvine · R01 · FY2023 · CA

A SIGNALING PATHWAY SPECIFIC FOR ALKYLATION DAMAGE

$353,076
Nima Mosammaparast · Washington University · R01 · FY2022 · CA

Project 2: Monitoring metabolism in GBM using hyperpolarized C-13 imaging and H-1 MRSI

$353,057
Janine Marie Lupo · University Of California, San Francisco · P50 · FY2020 · CA

Biospecimen and Biostatistics Core

$353,004
Susan M Chang · University Of California, San Francisco · P01 · FY2015 · CA

Systemic RNA interference to reactivate p53 tumor suppression

$352,899
Alexander H. Stegh · Northwestern University At Chicago · R01 · FY2021 · CA

Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)

$352,810
Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2019 · CA

Monocyte promotion of therapy resistance by immune and non-immune mechanisms

$352,801
Yi Lin · Mayo Clinic Rochester · R01 · FY2019 · CA

Genotypic Interactions in Brain Cancer Heterogeneity

$352,781
Frank Furnari · Ludwig Institute For Cancer Res Ltd · R01 · FY2014 · NS

X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research

$352,778
Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R37 · FY2023 · CA

EGFR signaling network adaptations to overcome RAS-induced membrane stress in glioblastoma

$352,763
Matthew J Lazzara · University Of Virginia · U54 · FY2024 · CA

Project 3: Targeting epigenetic regulators in cancer

$352,717
Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2017 · CA

Project 3: Targeting epigenetic regulators in cancer

$352,717
Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2020 · CA

Project 3: Targeting epigenetic regulators in cancer

$352,717
Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2018 · CA

Project 3: Targeting epigenetic regulators in cancer

$352,717
Jacqueline A. Lees · Massachusetts Institute Of Technology · P01 · FY2021 · CA

Preventing Glioma Cancer Stem Cell Dispersal Using Cdc2 Kinase Inhibitors

$352,708
Mark D Johnson · Brigham And Women'S Hospital · R01 · FY2014 · NS

Requirements for generation and maintenance of gliomas

$352,663
Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA

Requirements for generation and maintenance of gliomas

$352,663
Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA